Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

Resverlogix Corp T.RVX

Sector: Healthcare | Sub-Sector: Biotechnology
Alternate Symbol(s):  RVXCF

Resverlogix Corp is a clinical stage cardiovascular company. It is engaged in developing small molecules that selectively inhibit Bromodomain and ExtraTerminal domain (BET) proteins, a new and emerging target for high risk vascular diseases.
Price: $0.97 | Change: +$0.04 | %Change: +4.30%
Volume: 264,488 | Day High/Low: 0.97/0.93 | 52 Week High/Low: 1.00/0.405
View modes: 
0 stars

RE:RE:RE:STATINS INCREASE RISK T2D BY UP 46%

I took a quick glance at the article. "A total of 2,142 (24.5%) of the 8,749 nondiabetic men were on statin medication at baseline (65.9% on simvastatin, 18.1% on atorvastatin, 8.6% on rosuvastatin, ...read more
0 stars

Golden Cross Today!! Is RVX now becoming a momo play!!

Symbol Period                Daily                 Weekly            Inspect  rate and reply
0 stars

RE:RE:STATINS INCREASE RISK T2D BY UP 46%

MANY THANKS AGAIN TOINV FOR YOUR FARSIGHTED AND FOCUSED ANALYSIS. AS RESPECTS THE FINNISH T2D STUDY, I TOO HOPE WE WILL HEAR FROM OUR SCIENCE POSTERS. RE THE PROSPECTS OF RVX-208 RE THE ARTICLE...read more
0 stars

Morgan stanley all over this..

From a trading perspective I believe when the remaining 180k at .95 get's eaten up that we will quickly head over 1$. Cheers and good luck  rate and reply
5 stars

RE:STATINS INCREASE RISK T2D BY UP 46%

Hi Jkj. Thanks for another great post and for your digging. At fist glance, while it is unfortunate from a health perspective (that some statins increase the incidence of diabetes mellitus), from an...read more
5 stars

RE:RE:RE:RE:RE:NEW NR RVX

bfw: To continue with your thought, in 2013 due to the synergistic effect of the Rosuvastatin and RVX-208 combination of the ASSURED data analysis, was the basis for two provisional patent...read more
3.5 stars

STATINS INCREASE RISK T2D BY UP 46%

FOR THOSE OF INTEREST. IF THIS STUDY IS VALID RVX-208 MIGHT ALLOW LOWER DOSE OF THE STATIN LOWERING T2D RISK:  Liam Davenport | Disclosures   Statin therapy appears to increase the risk for type 2...read more
0 stars

RE:RE:RE:RE:RE:NEW NR RVX

I really APPRECIATE your posts and analysis...you do a PHENOMENAL JOB!.....I hope you continue all of the time and effort you put into this. Thanks again! long time suffering shareholder Emeritus!  rate and reply
3.5 stars

RE:RE:RE:RE:NEW NR RVX

Hi princeofcut. It's time for you to do your own due diligence. Of course analysis is limited by the data available but the huge step forward made by RVX with Emerald is the integration of large...read more
4 stars

RE:RE:RE:RE:NEW NR RVX

princeofcut wrote: toi, so as you are a math and stats person, here is a challenge that you should grasp, they are fundamentally limited by the data they evaluate....so a big question i still have is...read more
2.5 stars

RE:RE:RE:NEW NR RVX

toi, so as you are a math and stats person, here is a challenge that you should grasp, they are fundamentally limited by the data they evaluate....so a big question i still have is whether 208 needs...read more
5 stars

RE:RE:NEW NR RVX

Hi fouremm. First, thanks for the clear, concise and relevant perspective. My immediate reactions to the press release were as follows; First it reminded me of my posting yesterday at 3:11 (and...read more
5 stars

RE:RE:PARIS MEETING MARCH 9, DM PRESENTING??

FOR THOSE OF INTEREST, ANSWERED BY SARAH: THANKS SARAH:   Please see below. Certain times and dates will be available closer to the actual dates. Bio-Europe Spring 2015, Paris, France, March 9-11...read more
5 stars

RE:NEW NR RVX

Although I think this press release could have been worded much more effectively to address retail investors, I think it is very useful information as 1) it explains what has been taking so long 2) it...read more
5 stars

TID BITS ON EMERALD LOGIC

For those of interest:  GIGAOM-EMERALD LOGIC APRIL 2014  Think about being a hospital that wants to improve survival rates for patients. You have lots of data about patients — their medical...read more
0 stars

Any Dixie Chicks fans on this board?

That's about as up to date as I come.  "Ready to Run" seems as fitting a song to listen to today as any..... {^youtubevideo|(width)425|(height)264|(rel)False|(url)http://youtu.be/A2X7cN-QKJ8|(fs)True...read more
0 stars

emerald

As I read it the process has ben completed and RVX would have their road map.That is just my thought  rate and reply
0 stars

RE:Emerald

anthony: any thoughts as to how long this process generally takes? .....or anyone?? G1945V  rate and reply
5 stars

Emerald

I am pleased that the company is using this co to analyse complex and large amounts of data.Emerald probably know nothing about epigenetics but it has the capacity to turn out logically predictive...read more
0 stars

RE:RE:RE:RE:News out

Phase 3 (according to recent communications from the company) will be filed ("IND" filing) around April with first dosing by end of June. At least that was the last I had heard about it.  I think...read more